KẾT QUẢ PHẪU THUẬT BẮC CẦU ĐIỀU TRỊ BỆNH ĐỘNG MẠCH CHI DƯỚI TẠI BỆNH VIỆN ĐẠI HỌC Y HÀ NỘI

Abstract

Research Objective: To assess the early results of bypass surgery treatment for Peripheral Arterial Disease at Hanoi Medical University Hospital from January 2019 to July 2023. Study Population and Methods: This is a cross-sectional, retrospective descriptive study. All patients diagnosed with Peripheral Arterial Disease were treated using bypass surgery intervention method at Hanoi Medical University Hospital from January 2019 to July 2023. Results: There were 53 patients with a mean age of 65.07 ± 8.1 years. Male patients accounted for 87.5% of the study population. Patients presented with corresponding symptoms of claudication: 26.8% in stage IIB, 41.1% in stage III, and 32.1% with ischemic ulcers, gangrene, or necrosis of the toes (stage IV). The average duration of symptoms before hospital admission was 92.64 ± 291.21 days. Associated comorbidities included hypertension (85.7%), diabetes mellitus (48.2%), and previous history of stroke (10.7%). The most common anatomical site affected was the femoropopliteal segment (66.07%). The predominant surgical procedure performed was femoropopliteal bypass (41.1%), with the use of autogenous veins (57.14%) and artificial grafts (42.86%) as conduit materials. The average duration of surgery was 143.04 ± 45.04 minutes. No intraoperative complications were observed. The mean length of hospital stay post-surgery was 10.41 ± 7.11 days. Immediate postoperative complications occurred in 19.64% of cases, and early complications requiring reoperation occurred in 12.5% of cases. There were no patient died during treatment. Conclusion: The bypass surgery is a safe and highly effective method in treating Peripheral Arterial Disease at Hanoi Medical University Hospital.